Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1798-1807
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1798
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1798
Table 1 Patient demographics and current colonoscopy findings
n = 1051 | Previous colonoscopy = Yes, n = 319 (30.4%) | Previous colonoscopy = No/unknown, n = 732 (69.6%) | P value |
Sex | |||
Male | 174 (54.5%) | 389 (53.1%) | 0.68 |
Age | |||
50-64 | 151 (47.3%) | 438 (59.8%) | < 0.001 |
65 + | 168 (52.7%) | 294 (40.2%) | |
Median age | 65 (range 50-75) | 62 (range 50-75) | < 0.001 |
Family history of CRC | |||
Yes | 52 (16.3%) | 56 (7.7%) | < 0.001 |
Symptomatic | |||
Any symptoms | 149 (46.7%) | 258 (35.2%) | < 0.001 |
Rectal bleeding | 66 (20.7%) | 112 (15.3%) | 0.03 |
Change in bowel pattern | 65 (20.4%) | 116 (15.8%) | 0.09 |
Abdominal pain | 35 (11%) | 46 (6.3%) | 0.014 |
Weight loss | 11 (3.4%) | 34 (4.6%) | 0.28 |
Anemia | 19 (6.0%) | 40 (5.5%) | 0.75 |
Current colonoscopy bowel preparation | |||
Good/excellent | 204 (63.9%) | 532 (72.7%) | 0.014 |
Poor | 23 (7.2%) | 46 (6.3%) | |
Complete colonoscopy | 311 (97.5%) | 715 (97.7%) | 0.42 |
CRC detected | 4 (1.3%) | 38 (5.2%) | 0.003 |
A-SSL detected | 146 (45.8%) | 367 (50.1%) | 0.19 |
AA-SSL detected | 57 (17.8%) | 200 (27.3%) | 0.002 |
Advanced neoplasia | 60 (18.8%) | 221 (30.2%) | < 0.001 |
- Citation: Rattan N, Willmann L, Aston D, George S, Bassan M, Abi-Hanna D, Anandabaskaran S, Ermerak G, Ng W, Koo JH. To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World J Gastrointest Oncol 2022; 14(9): 1798-1807
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1798.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1798